To access this element change to forms mode OFF
Grant Award View - GA187496
The Neurofibromatosis type 1 (NF1) Cutaneous Neurofibroma Consortium:...
GA ID:
GA187496
Agency:
Department of Health and Aged Care
Approval Date:
11-Jun-2021
Publish Date:
31-Aug-2021
Category:
Health and Medical Research
Grant Term:
11-Jun-2021 to 31-May-2024
Value (AUD):
$1,607,737.60
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 20/21 1.1 Health Policy Research and Analysis
Grant Program:
MRFF_2020_Neurofibromatosis_Research_2021
Grant Activity:
The Neurofibromatosis type 1 (NF1) Cutaneous Neurofibroma Consortium: Identifying Genetic modifiers of disease burden to inform treatment pathways.
Purpose:
Neurofibromatosis type 1 (NF1) is the most common neurogenetic condition. Adult patients report cosmetic disfigurement due to distressing fleshy skin tumours as the greatest burden of living with NF1. There is no way to predict tumour severity which can range from less than100 to thousands. We will conduct a large genome-wide association study to identify genetic modifiers to understand disease variability and characterise potential treatment pathways.
GO ID:
GO Title:
MRFF – EPCDR Initiative – 2020 Neurofibromatosis Research Grant Opportunity
Internal Reference ID:
MRF2011006
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Newcastle
Recipient ABN:
15 736 576 735
Grant Recipient Location
Suburb:
Callaghan
Town/City:
Callaghan
Postcode:
2308
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW, QLD
Postcode:
Multiple
Country:
AUSTRALIA